Novel potent and m 2 -selective antimuscarinic compounds which penetrate the blood-brain barrier

By Cohen V.   Jin B.   Gitler M.   de la Cruz R.   Boulay S.   Sood V.   Zeeberg B.   Reba R.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 1, 1995-01 ,pp. : 61-69

Elsevier

Access to resources Recommend Favorite

Anticonvulsant activity of a mGlu 4 receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid

By Chapman A.G.   Talebi A.   Yip P.K.   Meldrum B.S.  

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 107-113

Elsevier

Access to resources Recommend Favorite

Novel, highly selective, muscarinic M3 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1475-1478

Informa Healthcare

Access to resources Recommend Favorite

Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?

By  

Current Medicinal Chemistry, Vol. 18, Iss. 36, 2011-12 ,pp. : 5528-5544

Bentham Science Publishers

Access to resources Recommend Favorite

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 131-137

Bentham Science Publishers

Access to resources Recommend Favorite